Literature DB >> 35566331

Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.

Ke Wang1, Ruoyu Shen1, Tingting Meng1, Fuqiang Hu1, Hong Yuan1.   

Abstract

Colorectal cancer (CRC) is a usual digestive tract malignancy and the third main cause of cancer death around the world, with a high occurrence rate and mortality rate. Conventional therapies for CRC have certain side effects and restrictions. However, the exciting thing is that with the rapid development of nanotechnology, nanoparticles have gradually become more valuable drug delivery systems than traditional therapies because of their capacity to control drug release and target CRC. This also promotes the application of nano-drug targeted delivery systems in the therapy of CRC. Moreover, to make nanoparticles have a better colon targeting effect, many approaches have been used, including nanoparticles targeting CRC and in response to environmental signals. In this review, we focus on various targeting mechanisms of CRC-targeted nanoparticles and their latest research progress in the last three years, hoping to give researchers some inspiration on the design of CRC-targeted nanoparticles.

Entities:  

Keywords:  colorectal cancer; drug delivery systems; nanoparticles; targeted therapy

Mesh:

Substances:

Year:  2022        PMID: 35566331      PMCID: PMC9099628          DOI: 10.3390/molecules27092981

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.927


  89 in total

Review 1.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

Review 2.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.

Authors:  Sarbari Acharya; Sanjeeb K Sahoo
Journal:  Adv Drug Deliv Rev       Date:  2010-10-20       Impact factor: 15.470

3.  Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment.

Authors:  Ranran Chen; Yuanjian Huang; Lu Wang; Jiahui Zhou; Yuqian Tan; Chaofan Peng; Peng Yang; Wen Peng; Jie Li; Qiou Gu; Yuchen Sheng; Yan Wang; Guoqiang Shao; Qing Zhang; Yueming Sun
Journal:  Biomater Sci       Date:  2021-02-04       Impact factor: 6.843

4.  Aminocellulose-Grafted Polymeric Nanoparticles for Selective Targeting of CHEK2-Deficient Colorectal Cancer.

Authors:  Anas Ahmad; Md Meraj Ansari; Rahul Kumar Verma; Rehan Khan
Journal:  ACS Appl Bio Mater       Date:  2021-06-03

5.  A biocompatible superparamagnetic chitosan-based nanoplatform enabling targeted SN-38 delivery for colorectal cancer therapy.

Authors:  Danjun Wu; Yi Li; Lixi Zhu; Wangyang Zhang; Shumin Xu; Yan Yang; Qinying Yan; Gensheng Yang
Journal:  Carbohydr Polym       Date:  2021-09-06       Impact factor: 9.381

Review 6.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

Authors:  H Maeda; G Y Bharate; J Daruwalla
Journal:  Eur J Pharm Biopharm       Date:  2008-12-03       Impact factor: 5.571

7.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

Review 8.  Lessons from patient-derived xenografts for better in vitro modeling of human cancer.

Authors:  Stephen Yiu Chuen Choi; Dong Lin; Peter W Gout; Colin C Collins; Yong Xu; Yuzhuo Wang
Journal:  Adv Drug Deliv Rev       Date:  2014-10-13       Impact factor: 15.470

9.  Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer.

Authors:  Sudhakar Jinka; Hari Krishnareddy Rachamalla; Tithi Bhattacharyya; Kathyayani Sridharan; Madan Mohan Chandra Sekhar Jaggarapu; Venu Yakati; Rajkumar Banerjee
Journal:  Biomed Mater       Date:  2021-02-18       Impact factor: 4.103

10.  Cancer immunotherapy in routine cost-effective cancer care?

Authors:  Sir Marc Feldmann
Journal:  EMBO Mol Med       Date:  2018-11       Impact factor: 12.137

View more
  1 in total

Review 1.  Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy.

Authors:  Ruogang Zhao; Jianhao Liu; Zhaohuan Li; Wenhui Zhang; Feng Wang; Bo Zhang
Journal:  Pharmaceutics       Date:  2022-07-25       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.